InvestorsHub Logo

king oil

02/15/18 7:18 PM

#745 RE: PorscheTech #744

The only recent coverage I could find was from Dec 2017:

Roth Capital initiates coverage on Moleculin Biotech (NASDAQ: MBRX) with a Buy rating and a price target of $8.00.